InBody for Reliable Body
Composition Analysis in Diabetology
Item 1
Item 2
Item 3
Item 4
Item 5
Item 6
InBody Applications

Advancing Diabetes Management with
Body Composition Analysis
Effective diabetes care requires more than traditional weight metrics. In diabetology, body composition analysis provides critical insights into the relationship between adiposity, muscle mass, and metabolic health, factors that strongly influence insulin resistance and glycemic control. Unlike BMI, InBody’s technology accurately measures visceral fat, skeletal muscle mass, and segmental body distribution, helping clinicians identify underlying drivers of type 2 diabetes and its related complications.
By incorporating body composition testing into diabetes management, healthcare professionals can enhance risk stratification, personalize nutritional and pharmacological interventions, and closely monitor treatment effectiveness. InBody’s clinically validated devices are trusted in hospitals, diabetes clinics, and research institutions worldwide, enabling evidence-based decision making and improving outcomes for patients with diabetes and metabolic disorders.
Advancing Diabetes Management with
Body Composition Analysis
Effective diabetes care requires more than traditional weight metrics. In diabetology, body composition analysis provides critical insights into the relationship between adiposity, muscle mass, and metabolic health, factors that strongly influence insulin resistance and glycemic control. Unlike BMI, InBody’s technology accurately measures visceral fat, skeletal muscle mass, and segmental body distribution, helping clinicians identify underlying drivers of type 2 diabetes and its related complications.
By incorporating body composition testing into diabetes management, healthcare professionals can enhance risk stratification, personalize nutritional and pharmacological interventions, and closely monitor treatment effectiveness. InBody’s clinically validated devices are trusted in hospitals, diabetes clinics, and research institutions worldwide, enabling evidence-based decision making and improving outcomes for patients with diabetes and metabolic disorders.

InBody in Cardiology
Visceral
Adiposity
Precise quantification of visceral fat supports cardiovascular and metabolic risk stratification.
Sarcopenia
Monitoring
Assessment of muscle mass and quality enables early detection of sarcopenia in patients with diabetes.
Insulin
Resistance
Body composition profiling enhances the identification of individuals at elevated risk of insulin resistance.
Complication
Screening
Segmental analysis assists in recognizing early body composition changes linked to diabetic complications.
Therapeutic
Evaluation
Objective metrics allow clinicians to monitor the impact of pharmacological and lifestyle interventions.
Renal Function
Support
Fluid compartment analysis contributes to early recognition of nephropathy-related imbalances.
Rehabilitation
Planning
Quantitative data guides personalized exercise and nutritional strategies in diabetes management.
Scientific
Validation
Clinical applicability is supported by a broad body of peer-reviewed research in diabetology and metabolic medicine.
The InBody BWA2.0S
in Diabology
The InBody BWA2.0S is particularly suited for diabetology, as it provides precise insights into body composition and fluid distribution, parameters closely linked to metabolic health and diabetic complications. Quantification of visceral fat enables accurate risk stratification for cardiovascular disease, while lean mass analysis supports early detection and management of sarcopenia, a frequent comorbidity in type 2 diabetes. By identifying subtle changes in body composition, the BWA2.0S aids in the early recognition of complications such as insulin resistance, nephropathy-related fluid imbalance, and impaired muscle quality.
In addition to diagnostic value, the BWA2.0S enhances therapy monitoring by objectively tracking the impact of pharmacological treatment, lifestyle interventions, and dietary management on body composition. Biomarkers such as phase angle provide prognostic insights into cellular integrity and overall metabolic health, complementing traditional laboratory findings. With rapid, non-invasive testing and strong validation in peer-reviewed research, the BWA2.0S equips diabetologists with a clinically robust tool for both individualized patient management and long-term outcome monitoring.

Trusted By
InBody is geïntegreerd met de grote fitness apparatuur en software providers zoals bijvoorbeeld Technogym, Milon, EGYM and MyZone. Leden van de sportschool kunnen nu gemakkelijk hun progressie bijhouden. Ook is het voor jou als fitness ondernemer zeer overzichtelijk gemaakt via de verschillende integratie mogelijkheden.


Results in just
30 seconds
An InBody Test takes only 30 seconds to complete. Ideal for a fast-paced environment such as hospitals, clinics and other practices.
Though the InBody Test results are presented to you quickly, the accuracy, precision and reliability remain unmatched.
Fast and efficient body composition measurements can save lives in critical situations. It helps the medical professional to better understand the current situation and act accordingly.
Without hesitation and based on reliable data.
Results in just
30 seconds
An InBody Test takes only 30 seconds to complete. Ideal for a fast-paced environment such as hospitals, clinics and other practices.
Though the InBody Test results are presented to you quickly, the accuracy, precision and reliability remain unmatched.
Fast and efficient body composition measurements can save lives in critical situations. It helps the medical professional to better understand the current situation and act accordingly.
Without hesitation and based on reliable data.